But the FDA and the Centers for Disease Control and Prevention (CDC) released a safety notice on May 9 recommending that adults over 60 years old pause use of the vaccine due to fatal complications.

The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

and the Centers for Disease Control and Prevention (CDC) are recommending a pause in the use of the chikungunya vaccine, called Ixchiq, for adults age 60 and older while they investigate reports of ...

Centres for Disease Control and Prevention (CDC) has issued an advisory urging American travellers over the age of 60 years ...

Harvard's beloved blonde takes the stage at CDC Theatre in Cranford by pink storm in this fun, upbeat story of self-discovery! CDC Theatre presents Legally Blonde, The Musical weekends from ...

WASHINGTON, April 29 (Reuters) - The National Academy of Sciences has canceled a workshop on preventing human bird flu infections after being told to stop work on the event by the U.S. Centers for ...

Additionally, the ACIP voted to recommend a precaution related to the use of Ixchiq in patients aged 65 years and older due to an ongoing investigation by the CDC of 6 cases of serious adverse events, ...

One in ten patients experience a “serious adverse event” after taking the abortion pill, according to a study released Monday by the Ethics and Public Policy Center (EPPC), a conservative ...

Researchers estimated that nearly 25,000 ED visits were related to semaglutide adverse events. They were surprised to learn that 16% involved hypoglycemia. An estimated 24,499 people visited the ...

Hamburg is former commissioner of the FDA and co-president of the InterAcademy Partnership. Fineberg is president of the Gordon and Betty Moore Foundation and past president of the Institute of ...